These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 3934994
1. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma. Alvarado CS, Faraj BA, Kim TH, Camp VM, Bain RP, Ragab AH. Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994 [Abstract] [Full Text] [Related]
2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma. Eldrup E, Clausen N, Scherling B, Schmiegelow K. Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538 [Abstract] [Full Text] [Related]
3. Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma. Johnson GA, Baker CA, Smith RT. Life Sci; 1980 May 12; 26(19):1591-8. PubMed ID: 6770210 [No Abstract] [Full Text] [Related]
10. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine. Ben-Jonathan N, Arbogast LA, Rhoades TA, Schillo KK, Pau KY, Jackson GL. Endocrinology; 1983 Jul 12; 113(1):216-21. PubMed ID: 6407822 [Abstract] [Full Text] [Related]
11. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis. Schöni MH, Türler K, Käser H, Kraemer R. Eur J Clin Invest; 1990 Jun 12; 20(3):272-8. PubMed ID: 2114988 [Abstract] [Full Text] [Related]
12. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease. Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ. Acta Neurol Scand; 1995 Aug 12; 92(2):116-21. PubMed ID: 7484057 [Abstract] [Full Text] [Related]
13. Methylated catecholamine metabolites for diagnosis of neuroblastoma. Candito M, Thyss A, Albertini M, Deville A, Politano S, Mariani R, Chambon P. Med Pediatr Oncol; 1992 Aug 12; 20(3):215-20. PubMed ID: 1574031 [Abstract] [Full Text] [Related]
14. [Serum catecholamine concentrations and hemodynamics during operations on 23 children with neuroblastoma]. Fujimura H, Kitamura S, Kawahara R, Takada Y, Ohnishi Y, Maeda L. Masui; 1992 Jun 12; 41(6):919-24. PubMed ID: 1613951 [Abstract] [Full Text] [Related]
15. DOPA metabolism in neuroblastoma. Helson L, Johnson GA, Smith R. Med Pediatr Oncol; 1980 Jun 12; 8(4):317-22. PubMed ID: 6779102 [Abstract] [Full Text] [Related]
16. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. Kuchel O, Buu NT, Edwards DJ. J Lab Clin Med; 1990 Apr 12; 115(4):449-53. PubMed ID: 1969915 [Abstract] [Full Text] [Related]
17. Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. Its relation to hypertension. Puyo A, Levin G, Armando I, Barontini M. Hypertension; 1988 Feb 12; 11(2 Pt 2):I202-6. PubMed ID: 3346058 [Abstract] [Full Text] [Related]
18. Sources and significance of plasma levels of catechols and their metabolites in humans. Goldstein DS, Eisenhofer G, Kopin IJ. J Pharmacol Exp Ther; 2003 Jun 12; 305(3):800-11. PubMed ID: 12649306 [Abstract] [Full Text] [Related]
19. Effect of in vitro hemolysis on assay of plasma catecholamines and DOPA. Smith RT. Clin Chem; 1980 Aug 12; 26(9):1354-6. PubMed ID: 6772343 [Abstract] [Full Text] [Related]
20. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M. Pediatrics; 1978 Jul 12; 62(1):77-83. PubMed ID: 683787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]